Please use this identifier to cite or link to this item: https://doi.org/10.1002/hed.23116
DC FieldValue
dc.titlePrognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma
dc.contributor.authorPan, J.
dc.contributor.authorTang, T.
dc.contributor.authorXu, L.
dc.contributor.authorLu, J.J.
dc.contributor.authorLin, S.
dc.contributor.authorQiu, S.
dc.contributor.authorChen, G.
dc.contributor.authorTham, I.W.K.
dc.date.accessioned2016-07-08T09:27:02Z
dc.date.available2016-07-08T09:27:02Z
dc.date.issued2013-09
dc.identifier.citationPan, J., Tang, T., Xu, L., Lu, J.J., Lin, S., Qiu, S., Chen, G., Tham, I.W.K. (2013-09). Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. Head and Neck 35 (9) : 1238-1247. ScholarBank@NUS Repository. https://doi.org/10.1002/hed.23116
dc.identifier.issn10433074
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125438
dc.description.abstractBackground The association between expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), and the long-term outcomes in treated nasopharyngeal carcinoma (NPC) was studied. Methods Expression of COX-2, VEGF, and EGFR by immunohistochemical (IHC) staining was assessed in 128 patients with NPC. Overall survival (OS), disease-free survival (DFS), locoregional control, and distant metastasis-free survival rates were compared for different expression levels of each marker. Multivariate analysis was by the Cox regression model. Results Median follow-up after radiation therapy ± chemotherapy was 116 months. Univariate and multivariate analyses demonstrated that COX-2, VEGF, EGFR, and clinical stage were all independent predictors for OS, DFS, locoregional control, and distant metastasis-free survival rates. Conclusions High expression of COX-2, VEGF, and EGFR were independent adverse prognostic factors for long-term outcomes in nonmetastatic NPC independent of clinical stage. © 2012 Wiley Periodicals, Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/hed.23116
dc.sourceScopus
dc.subjectcyclooxygenase 2
dc.subjectepidermal growth factor receptor
dc.subjectnasopharyngeal neoplasms
dc.subjectprognosis
dc.subjectvascular endothelial growth factor
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1002/hed.23116
dc.description.sourcetitleHead and Neck
dc.description.volume35
dc.description.issue9
dc.description.page1238-1247
dc.description.codenHEANE
dc.identifier.isiut000323317000011
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.